Qube Research & Technologies (QRT)’s Catalyst Pharmaceutical CPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $22M | Buy |
1,014,410
+254,114
| +33% | +$5.51M | 0.02% | 588 |
|
|
2025
Q1 | $18.4M | Buy |
760,296
+101,044
| +15% | +$2.45M | 0.02% | 576 |
|
|
2024
Q4 | $13.8M | Sell |
659,252
-7,988
| -1% | -$167K | 0.02% | 683 |
|
|
2024
Q3 | $13.3M | Buy |
667,240
+538,506
| +418% | +$10.7M | 0.02% | 641 |
|
|
2024
Q2 | $1.99M | Buy |
128,734
+38,484
| +43% | +$596K | ﹤0.01% | 1367 |
|
|
2024
Q1 | $1.44M | Buy |
+90,250
| New | +$1.44M | ﹤0.01% | 1646 |
|
|
2023
Q4 | – | Sell |
-64,578
| Closed | -$755K | – | 3944 |
|
|
2023
Q3 | $755K | Buy |
+64,578
| New | +$755K | ﹤0.01% | 1517 |
|
|
2023
Q1 | – | Sell |
-121,873
| Closed | -$2.27M | – | 2532 |
|
|
2022
Q4 | $2.27M | Buy |
+121,873
| New | +$2.27M | 0.01% | 831 |
|
|
2022
Q3 | – | Sell |
-122,638
| Closed | -$860K | – | 2518 |
|
|
2022
Q2 | $860K | Sell |
122,638
-31,071
| -20% | -$218K | 0.01% | 1150 |
|
|
2022
Q1 | $1.27M | Sell |
153,709
-24,611
| -14% | -$204K | 0.01% | 1025 |
|
|
2021
Q4 | $1.21M | Buy |
178,320
+93,818
| +111% | +$635K | 0.01% | 1078 |
|
|
2021
Q3 | $448K | Buy |
84,502
+40,238
| +91% | +$213K | 0.01% | 1269 |
|
|
2021
Q2 | $255K | Buy |
+44,264
| New | +$255K | ﹤0.01% | 1660 |
|
|
2020
Q2 | – | Sell |
-34,024
| Closed | -$131K | – | 1743 |
|
|
2020
Q1 | $131K | Buy |
+34,024
| New | +$131K | 0.01% | 928 |
|